CRISPR Therapeutics and Sirius Therapeutics have formed a strategic ... clinical trials and pipeline products and programs, including, without limitation, expectations regarding data, safety ...

SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Sirius Therapeutics today ... our clinical programs and expand our pipeline, to deliver “transformative siRNA therapeutics for patients with chronic ...

Sirius Therapeutics Inc. raised nearly $50 million in a series B2 financing round May 9 to support its pipeline of small interfering RNA (siRNA) molecules for cardiovascular disease indications.